Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE) two randomised, double-masked,...

Heier Jeffrey S., Khanani Arshad M., Ruiz Carlos Quezada, Basu Karen, Ferrone Philip J., Brittain Christopher, Figueroa Marta S., Lin Hugh, Holz Frank G., Patel Vaibhavi, Lai Timothy Y. Y., Silverman David, Tóth-Molnár Edit, Zatorska Barbara, Kollaborációs szervezet: TENAYA and LUCERNE Investigators
2022